Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
Unknown statusNCT02069067
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to describe how often advanced cancer patients experience breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these treatments are.
Study details
- Official title
- Multicenter Observational Study of the Incidence and Treatment Modalities of Breakthrough Cancer Pain in Patients With Chronic Cancer Pain
- Conditions
- Advanced Cancer
- Sponsor
- National Cancer Institute, Naples
- Start date
- 2011-12
- Primary completion
- 2023-12
- Sex
- All
- Results posted
- No results posted in this snapshot
- Countries
- Italy
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of neoplasm in advanced stage * Chronic pain controlled for at least one week with opioids 60 mg / day morphine equivalent * 1-6 episodes of BTcP within any of 3 days previous to registration into study * Signed Informed Consent Exclusion Criteria: · More than 6 episodes of BTcP within any of 3 days previous to registration into study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02069067